[go: up one dir, main page]

Gupta et al., 2011 - Google Patents

Rapid histochemistry using slow off-rate modified aptamers with anionic competition

Gupta et al., 2011

View PDF
Document ID
102476209598231120
Author
Gupta S
Thirstrup D
Jarvis T
Schneider D
Wilcox S
Carter J
Zhang C
Gelinas A
Weiss A
Janjic N
Baird G
Publication year
Publication venue
Applied Immunohistochemistry & Molecular Morphology

External Links

Snippet

MATERIALS AND METHODS Buffer constituents were purchased from Sigma-Aldrich (St Louis, MO). SOMAmers to the HER2 and EGFR proteins were selected by SomaLogic, Inc with a novel SELEX procedure. Details of the SELEX process are as described elsewhere. 7 …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Gupta et al. Rapid histochemistry using slow off-rate modified aptamers with anionic competition
Fareh et al. TRBP ensures efficient Dicer processing of precursor microRNA in RNA-crowded environments
Pessina et al. Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors
Jagdis et al. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma
Liu et al. A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion
JP6910145B2 (en) Staining on glass slides by primer extension
Catena et al. Ruthenium counterstaining for imaging mass cytometry
Giedt et al. Single-cell barcode analysis provides a rapid readout of cellular signaling pathways in clinical specimens
JP2012177706A (en) Comprehensive diagnostic testing for personalized anticancer chemotherapy (pac)
ES2799705T3 (en) In-situ imaging and cyclic sample multiplexing procedures
Adeniran et al. Improved preservation of ovarian tissue morphology that is compatible with antigen detection using a fixative mixture of formalin and acetic acid
Monné Rodríguez et al. European society of toxicologic pathology (Pathology 2.0 molecular pathology special interest Group): review of in situ hybridization techniques for drug research and development
US20160274085A1 (en) 3d cell culture and ex vivo drug testing methods
Penheiter et al. Transcriptomic and immunohistochemical profiling of SLC6A14 in pancreatic ductal adenocarcinoma
Isidro et al. Double immunofluorescent staining of rat macrophages in formalin-fixed paraffin-embedded tissue using two monoclonal mouse antibodies
Oorschot et al. TEM, SEM, and STEM-based immuno-CLEM workflows offer complementary advantages
Cruz Da Silva et al. Bioimaging nucleic-acid aptamers with different specificities in human glioblastoma tissues highlights tumoral heterogeneity
Furrer et al. Concordance of HER2 immunohistochemistry and fluorescence in situ hybridization using tissue microarray in breast cancer
Gilbertson et al. Amyloid typing: experience from a large referral centre
Van Bockstal et al. Evaluation of trophoblast cell surface antigen-2 (TROP2) protein expression in chemotherapy-resistant and metastatic breast carcinomas
Miller et al. Development of an immunohistochemical assay to detect the ataxia-telangiectasia mutated (ATM) protein in gastric carcinoma
WO2020176534A1 (en) Multiplexed signal amplification methods using enzymatic based chemical deposition
Kim et al. KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas
Karreman et al. Novel contrasting and labeling procedures for correlative microscopy of thawed cryosections
Goebl et al. Development of a sensitive and specific in situ hybridization technique for the cellular localization of antisense oligodeoxynucleotide drugs in tissue sections